HomeNewsBusinessMoneycontrol ResearchIdeas for Profit | Bodal Chemicals: Vertical integration, better product mix holds promise on margin; accumulate

Ideas for Profit | Bodal Chemicals: Vertical integration, better product mix holds promise on margin; accumulate

March 07, 2019 / 15:11 IST
Story continues below Advertisement

Anubhav Sahu Moneycontrol Research

Highlights: - Revenue growth led by higher exports and better pricing
Addition of Thionyl Chloride capacity aids vertical integration
Stablising pricing, better product mix and retail exposure positive for margin
-------------------------------------------------

In its Q3 results, dyes major Bodal Chemicals posted a mixed set of earnings, where in margin was impacted due to product price deflation and high-cost raw material inventory.

Standalone Q3 financials Source: Company

Key positives Sales improved nine percent year-on-year (YoY) led by higher pricing of dyes and dye intermediates compared to last year. Higher exports and better product mix were the key supportive factors. Sequentially, there has been a decline in the price of finished products.

Exports surged 78 percent and now constitute 47 percent of sales compared to 28 percent in Q3 FY18, which speaks volumes about its improving geographical reach.

Story continues below Advertisement

On the capex front, during the quarter under review, company added thionyl chloride (TC) capacity of 36,000 tonne per year, which is a key step towards company’s backward and forward integration in the vinyl sulphone value chain. Commercial operations are expected to start by Q4 FY19-end.

In case of its joint venture for the water treatment chemical business - Trion Chemicals, the management expects improved near term performance. It’s noteworthy that the JV began operations in Q1 FY19. In Q3, Trion’s operations reached near about break even at the EBITDA level. This has been achieved due to softening input costs and stable finished goods prices. The company hopes to achieve break even at the net profit level within the next three-to-four months.